Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: LISATA THERAPEUTICS is not directly mentioned in the provided information, but it is important to note that several companies in the biopharmaceutical industry, including Neurocrine Biosciences and Avidity Biosciences, are making significant advancements in treatments for neurological and cancer-related conditions. Additionally, innovative technologies are being explored, such as controlling games with thought, showcasing the evolving intersection of neuroscience and technology.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.